Beatriz Castelo Fernández (Beatriz Castelo)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 10

Top Topics

Metastatic Breast Cancer

Neuropathic Pain

Photodynamic Therapy

Top Venues

Future oncology (London, England)

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ana López González, Sonia Del Barco Berrón, Isabel Grau, Maria Galan, Beatriz Castelo Fernández, Cortes Salgado Alfonso, Pedro Sánchez Rovira, Alejandro Martinez-Bueno, Xavier Gonzalez, Almudena García, Petra Gener, Leonardo Mina, Daniel Alcalá-López, Miguel Sampayo, Javier Cortes, José Manuel Pérez-Garcia, Antonio Llombart-Cussac, Elena López-Miranda
Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study. Cancers 14 (23) (2022)
Paula González Villarroel, Josep Gumà Padró, Gloria Marquina, Noelia Martínez Jáñez, Emilio Esteban González, Antonio Antón, Miguel Berzosa Sánchez, Alberto Rodrigo Cáceres, Rafael López, Roberto Escala Cornejo, Pablo Borrega García, Raquel Marse Fabregat, Beatriz Castelo Fernández, Cristina López Bermudo, Carlos Camps
Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study. Future oncology (London, England) (2022)
Paula González Villarroel, Josep Gumà Padró, Gloria Marquina, Noelia Martínez Jáñez, Emilio Esteban González, Antonio Antón, Miguel Berzosa Sánchez, Alberto Rodrigo Cáceres, Rafael López, Roberto Escala Cornejo, Pablo Borrega García, Raquel Marse Fabregat, Beatriz Castelo Fernández, Cristina López Bermudo, Carlos Camps
Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study. Future oncology (London, England) 18 (35) (2022)
Carles Zafón, Beatriz Castelo Fernández
Use of multikinase inhibitors/lenvatinib in singular thyroid cancer scenarios. Cancer medicine (2022)
Paula González Villarroel, Josep Gumà Padró, Gloria Marquina, Noelia Martínez Jáñez, Emilio Esteban González, Antonio Antón, Miguel Berzosa Sánchez, Alberto Rodrigo Cáceres, Rafael López, Roberto Escala Cornejo, Pablo Borrega García, Raquel Marse Fabregat, Beatriz Castelo Fernández, Cristina López Bermudo, Carlos Camps
Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study. Future oncology (London, England) 18 (35) (2022)
Paula González Villarroel, Josep Gumà Padró, Gloria Marquina, Noelia Martínez Jáñez, Emilio Esteban González, Antonio Antón, Miguel Berzosa Sánchez, Alberto Rodrigo Cáceres, Rafael López, Roberto Escala Cornejo, Pablo Borrega García, Raquel Marse Fabregat, Beatriz Castelo Fernández, Cristina López Bermudo, Carlos Camps
Increased quality of life in patients with breakthrough cancer pain after individualized therapy: the CAVIDIOM study. Future oncology (London, England) 18 (35) (2022)
Ana López González, Sonia Del Barco Berrón, Isabel Grau, Maria Galan, Beatriz Castelo Fernández, Cortes Salgado Alfonso, Pedro Sánchez Rovira, Alejandro Martinez-Bueno, Xavier Gonzalez, Almudena García, Petra Gener, Leonardo Mina, Daniel Alcalá-López, Miguel Sampayo, Javier Cortes, José Manuel Pérez-Garcia, Antonio Llombart-Cussac, Elena López-Miranda
Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study. Cancers 14 (23) (2022)
Ana López González, Sonia Del Barco Berrón, Isabel Grau, Maria Galan, Beatriz Castelo Fernández, Cortes Salgado Alfonso, Pedro Sánchez Rovira, Alejandro Martinez-Bueno, Xavier Gonzalez, Almudena García, Petra Gener, Leonardo Mina, Daniel Alcalá-López, Miguel Sampayo, Javier Cortes, José Manuel Pérez-Garcia, Antonio Llombart-Cussac, Elena López-Miranda
Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study. Cancers 14 (23) (2022)
Ana López González, Sonia Del Barco Berrón, Isabel Grau, Maria Galan, Beatriz Castelo Fernández, Cortes Salgado Alfonso, Pedro Sánchez Rovira, Alejandro Martinez-Bueno, Xavier Gonzalez, Almudena García, Petra Gener, Leonardo Mina, Daniel Alcalá-López, Miguel Sampayo, Javier Cortes, José Manuel Pérez-Garcia, Antonio Llombart-Cussac, Elena López-Miranda
Challenging Endocrine Sensitivity of Hormone Receptor-Positive/HER2-Negative Advanced Breast Cancer with the Combination of Eribulin and Endocrine Therapy: The REVERT Study. Cancers 14 (23) (2022)
Laura Ciria-Suarez, Paula Jiménez-Fonseca, María Palacín-Lois, Mónica Antoñanzas-Basa, Ana Fernández-Montes, Aranzazu Manzano-Fernández, Beatriz Castelo Fernández, Elena Asensio-Martínez, Susana Hernando-Polo, Caterina Calderon
Breast cancer patient experiences through a journey map: A qualitative study. PloS one 16 (9) (2021)